Introduction
A deficiency of coenyzme Q10 (CoQ10) was found in the gingiva of patients with periodontal dis-ease1-8). These studies indicated that restoration of CoQ10 levels in the diseased tissue would allow increased bioenergetics to generate new tissue.
Several clinical trials with oral administration of CoQ10 to patients with periodontal disease were conducted. Wilkinson et al.4) administered 50mg of CoQ10 for 3 weeks to patients under routine care for periodontitis. The periodontal score and pocket depth decreased. Healing was so good in due time that biopsy sites were difficult to locate. Next, Wilkinson et al.5) treated patients with periodontitis on a double-blind basis with CoQ10 and a matching placebo. The treatment was with 50mg of CoQ10 for 3 weeks and was significant. Before decoding, all 8 patients receiving the placebo were correctly assigned. A double-blind trial was also conducted on 56 patients by Iwamoto et al.6) . The patients were treated with 60mg of CoQ10 per day or a placebo for 4 weeks without any local treatment. The score of tooth mobility and pocket, depth were significantly improved in the CoQ10 group, but not in the placebo group. Shizukuishi et al.7) evaluated the effect of CoQ10 on the oxidative metabolism in the gingiva of patients with periodontal disease using tissue reflectance spectrophotometry. The clinical results by criteria of gingival index, pocket depth, and tooth mobility were significantly positive after 8 weeks of treatment with CoQ10 at a dosage of 60mg per day. The spectrophotometry results suggested that the administration of CoQ10 improves the oxygen utilization in the gingiva. These clinical effects of CoQ10 were also observed in an animal model. Shizukuishi et al.8) administered CoQ10 for 2 weeks to dogs with experimentally induced periodontitis. The administration increased the CoQ10 levels in the diseased tissue. The therapy with CoQ10 was effective for suppressing advanced periodontal inflammation.
These previous successful clinical trials with CoQ10 were conducted during periods of up to 2 months. It has become clear that the disease is a period of tissue destruction caused by an imbalance in the host/ parasite equilibriums), and that frequent monitoring and treatment should prevent the recurrence of inflam-mation10).
We have determined the results of oral administration of CoQ10 on reduction and elimination of subgingival microorganisms in patients with periodontal diseases during trials of 2 and 6 months.
Materials and Methods
The 2-month trial of therapy with CoQ10
Twenty-two patients with periodontal disease, 11 males and 11 females, ages 33 to 66, participated in this trial. They were volunteers, and were treated orally with 100mg of CoQ10 per day for 2 months. Informed consent forms were signed prior to the study. Periodontal examinations were made before and during the trial. The patients were not given any routine periodontal treatment, and the staff gave no information about oral hygiene to the patients.
The gingival index11) and plaque index12) were the criteria used to assess the degrees of gingival inflammation and accumulation of plaque on the teeth. The periodontal pocket depth was measured in interdental regions of the buccal gingiva in both maxilla and mandible. The deepest pocket which was measured before administration of CoQ10 was selected for direct examination of oral bacteria with a microscope. The subgingival plaques were obtained with a curette, dispersed in physiological saline containing 1% gelatin, and prepared for analysis by phase contrast microscopy. The biopsies were viewed with a DS/300 microscope system (Dental Scientific Systems, Inc., VA). Following the manufacturer's instructions, small spirochetes, large spirochetes, spinning rods, spiral rods, small gliding rods, large gliding rods, and palisading rods were identified on the basis of cellular morphology and active motility. The following scores were used in each category: 0 , no bacterial cells; 1, 1-9 cells; 2, 10-39 cells; and 3, more than 40 cells.
The 6-month trial of therapy with CoQ10
Eleven patients with periodontal disease participated in this trial. They were volunteers and were treated orally with 100mg per day for 6 months. Informed consent forms were signed prior to the study .
Periodontal examinations were made on day 0, and after 2-and 6-month periods . During the CoQ10 treatment, they did not receive any ordinary periodontal treatment and the examiner gave no information about oral hygiene. The gingival index and plaque index were assessed. Periodontal pocket depth was measured in interdental regions of the buccal gingiva. Plastic stents were used to make reliable measurements of the pocket depth13). Microscopic analysis of plaque biopsies was performed as described for the 2-month study.
Statistical analysis
The Wilcoxon test was used to test scores in microscopic analysis. Changes from the initial values were tested with repeated-measures ANOVA of contrast variables using SAS software.
Results

Therapy with CoQ10 for 2 months
The changes in the gingival index, plaque index, and pocket depth following the administration of CoQ10 are shown in Table 1 . The gingival index and pocket depth significantly decreased (p<0.001).
The plaque index showed no change. Table 2 shows the changes of scores in microscopic analysis for the subgingival microorganisms after taking CoQ10. The scores in the categories are summarized for motile rods and spirochetes. Both types of motile microorganisms showed significant reduction (p<0.01-0.02) after the therapy. In 4 patients, the microorganisms completely disappeared.
Therapy with CoQ10 for 6 months Table 3 shows changes in the gingival index and plaque index during the administration of CoQ10.
The patients had slight to moderate gingival inflammation at the beginning of the study. Nine out of 10 patients showed a decrease in gingival inflammation, but the plaque index showed no change. Pocket depth ranging from 2.2 to 4.7mm at the beginning of therapy decreased during the administration (Table   4 ); the decrease was significant at <0.05 after 2 months. In 3 out 10 patients who had significant pockets before the study, the pockets disappeared during the therapy. The microscopic data from the therapy are in Table 5 . Patients # 1 and # 5 showed a remarkable reduction of both spirochetes and motile rods.
The scores for motile rods decreased in 7 patients. Changes in the gingival index, pocket depth, number of significant pockets, and score in motile rods were statistically significant in both the 2-month and the 6-month periods.
Discussion
Recently, Hanioka et al. 14, 15) suggested that the oxygen supply for inflamed gingiva may be increased to some extent by conditions of nutrition or management, but not sufficiently to fulfill the requirement for oxygen in humans and in dogs. The oral administration of CoQ10 increased the CoQ10 levels and activity of the CoQ10-dependent enzymes in inflamed dog gingiva8) and in the oxygen utilization in inflamed human gingiva7). Thus, the decreases in gingival index and the pocket depth result from correction of a deficiency of CoQ10, and the restoration of the metabolic energy required for the diseased tissue. The decreases in pocket depth were positive, but the gingival inflammation was not cured during the limited 2-month Table 1 Data on the gingival index, plague index and pocket depth during administration of CoQ10 for 2 months trial. Accordingly, administration of CoQ10 to patients with periodontal disease will likely be more beneficial when continued for longer than 2 months, and this was the basis for the 6-month trial described here.
Other workers have shown interest in the motility observed in subgingival plaque biopsies by microscopic study as a measure of disease or a predictor of future periodontal disease16). Data from phase contrast and dark field microscopic analyses have been correlated with clinical features of periodontal disease, and the ratio of motile rods and spirochetes increases during disease of periodontal tissue17-19). These studies indicated that increased motility can be useful as a criterion of increased microbial disease. Oral administration of CoQ10 decreases motility and improves gingival health.
Periodontal disease is correlated with actual tissue destruction caused by an imbalance in host defense/parasite equilibrium. Environmental factors, such as plaque accumulation, can shift the host defense/ parasite balance in favor of the microflora. Our trials were planned so that the environmental factor of plaque would not change. No significant change was observed in plaque accumulation for our patients.
The decreases in the gingival index and pocket depth are understood to result from correction of Table 3 Data on the gingival index and the plaque index during the administration of CoQ10 for 2 and 6 months 
